Company Filing History:
Years Active: 2012-2014
Title: Hitomi Togo: Innovator in Recombinant Factor X Technology
Introduction
Hitomi Togo is a prominent inventor based in Kikuchi, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant factor X. With a total of 3 patents to her name, Togo's work has the potential to impact therapeutic applications significantly.
Latest Patents
One of her latest patents is focused on recombinant factor X with no glycosylation and the method for preparing the same. This invention provides a Factor X with high activity, which is crucial for various medical applications. The method described allows for the efficient preparation of a recombinant, two-chain factor X by intervening glycosylation at specific amino acid sequences essential for glycosylation. This innovative approach enables the expression of a recombinant factor X without glycosylation, enhancing its efficacy.
Career Highlights
Throughout her career, Hitomi Togo has worked with notable organizations, including the Juridical Foundation Chemo-Sero-Therapeutic Research Institute and the Chemo-Sero-Therapeutic Research Institute. Her work in these institutions has allowed her to advance her research and contribute to the field of therapeutic development.
Collaborations
Hitomi has collaborated with esteemed colleagues such as Kenji Soejima and Takayuki Imamura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hitomi Togo's contributions to the field of biotechnology, particularly in recombinant factor X technology, highlight her role as a leading inventor. Her innovative methods and collaborative efforts continue to pave the way for advancements in therapeutic applications.